A humanized eNAMPT -neutralizing monoclonal antibody reduces cancer-induced bone pain and osteoclastogenesis in murine breast cancer model.

Journal: Frontiers in pain research (Lausanne, Switzerland) •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Mathur NC, Villaroel E, Villaroel I, et al. (2026). "A humanized eNAMPT -neutralizing monoclonal antibody reduces cancer-induced bone pain and osteoclastogenesis in murine breast cancer model.". Frontiers in pain research (Lausanne, Switzerland). https://doi.org/10.3389/fpain.2026.1955262